Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Antipsychotic long-acting injections: prescribing practice in the UK.

Barnes TR, Shingleton-Smith A, Paton C.

Br J Psychiatry Suppl. 2009 Nov;52:S37-42. doi: 10.1192/bjp.195.52.s37.

PMID:
19880915
2.

Explicit review of risperidone long-acting injection prescribing practice.

Wheeler A, Vanderpyl J, Carswell C, Stojkovic M, Robinson E.

J Clin Pharm Ther. 2011 Dec;36(6):651-63. doi: 10.1111/j.1365-2710.2010.01219.x. Epub 2010 Nov 5.

PMID:
22023342
3.

Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.

Patel MX, Haddad PM, Chaudhry IB, McLoughlin S, Husain N, David AS.

J Psychopharmacol. 2010 Oct;24(10):1473-82. doi: 10.1177/0269881109104882. Epub 2009 May 28.

PMID:
19477883
4.

Community treatment orders and antipsychotic long-acting injections.

Lambert TJ, Singh BS, Patel MX.

Br J Psychiatry Suppl. 2009 Nov;52:S57-62. doi: 10.1192/bjp.195.52.s57.

PMID:
19880919
5.

Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.

Taylor DM, Young CL, Mace S, Patel MX.

J Clin Psychiatry. 2004 Aug;65(8):1076-83.

PMID:
15323592
6.
7.

Diffusion of a new drug: a comparative analysis of adoption, treatment complexity, and persistence of risperidone long-acting injectable therapy in the Netherlands.

Pechlivanoglou P, Vehof J, van Agthoven M, de Jong-van den Berg LT, Postma MJ.

Clin Ther. 2010 Jan;32(1):108-18. doi: 10.1016/j.clinthera.2010.01.008.

PMID:
20171417
8.

Clinical guideline recommendations for antipsychotic long-acting injections.

Kane JM, Garcia-Ribera C.

Br J Psychiatry Suppl. 2009 Nov;52:S63-7. doi: 10.1192/bjp.195.52.s63. Review.

PMID:
19880920
9.

Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications.

Aggarwal NK, Sernyak MJ, Rosenheck RA.

J Clin Psychopharmacol. 2012 Jun;32(3):323-8. doi: 10.1097/JCP.0b013e31825244f6.

PMID:
22544006
10.

Attitudes of psychiatrists toward antipsychotic depot medication.

Heres S, Hamann J, Kissling W, Leucht S.

J Clin Psychiatry. 2006 Dec;67(12):1948-53.

PMID:
17194274
11.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
12.

Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large Medicaid population.

Boaz TL, Constantine RJ, Robst J, Becker MA, Howe AM.

J Clin Psychiatry. 2011 Aug;72(8):1079-85. doi: 10.4088/JCP.09m05348yel. Epub 2010 Oct 19.

PMID:
21034690
13.

Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services.

Barnes TR, Banerjee S, Collins N, Treloar A, McIntyre SM, Paton C.

Br J Psychiatry. 2012 Sep;201(3):221-6. doi: 10.1192/bjp.bp.111.107631. Epub 2012 Jul 12.

14.

Survey of depot antipsychotic prescribing in southern Adelaide.

Herriot P, Kheirani K.

Australas Psychiatry. 2005 Sep;13(3):253-7.

PMID:
16174198
15.

A prospective study on the pattern of medication use for schizophrenia in the outpatient pharmacy department, Hospital Tengku Ampuan Rahimah, Selangor, Malaysia.

Ponto T, Ismail NI, Abdul Majeed AB, Marmaya NH, Zakaria ZA.

Methods Find Exp Clin Pharmacol. 2010 Jul-Aug;32(6):427-32. doi: 10.1358/mf.2010.32.6.1477907.

PMID:
20852752
16.

Second-generation antipsychotic long-acting injections: systematic review.

Fleischhacker WW.

Br J Psychiatry Suppl. 2009 Nov;52:S29-36. doi: 10.1192/bjp.195.52.s29. Review.

PMID:
19880914
17.
18.

A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.

Iyer S, Banks N, Roy MA, Tibbo P, Williams R, Manchanda R, Chue P, Malla A.

Can J Psychiatry. 2013 May;58(5 Suppl 1):23S-9S.

PMID:
23945064
19.

Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries.

Barbui C, Nosè M, Mazzi MA, Bindman J, Leese M, Schene A, Becker T, Angermeyer MC, Koeter M, Gray R, Tansella M.

Int Clin Psychopharmacol. 2006 Mar;21(2):73-9.

PMID:
16421457
20.

Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.

Owen RR, Fischer EP, Kirchner JE, Thrush CR, Williams DK, Cuffel BJ, Elliott CE, Booth BM.

Am J Med Qual. 2003 Jul-Aug;18(4):140-6.

PMID:
12934949
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk